Trial
NCT04973007
Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
Bracco Diagnostics, Inc; National Cancer Institute (NCI)
Condition
Oligometastatic Disease
Intervention
Gadoxetate disodium
Why stopped
Low Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-22